Apelin-17 vs Apelin-36 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-17 is a 17-amino acid C-terminal fragment of the prepro-apelin precursor that binds and activates the APJ receptor (now APLNR) with the highest potency of all naturally occurring apelin isoforms. While apelin-13 is the best-characterized isoform, apelin-17 shows greater re...
Calculate Apelin-17 dose →Apelin-36 is the full-length 36-amino acid form of the apelin peptide family, encoded by the APLN gene. It activates the APJ (APLNR) receptor, a Gi-coupled GPCR, producing cardiovascular effects including vasodilation, positive inotropy, and cardioprotection. The largest naturall...
Calculate Apelin-36 dose →| Parameter | Apelin-17 | Apelin-36 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical / Phase I | Preclinical / Phase 2 |
| Half-Life | ~3-5 minutes IV (longer than apelin-13) | 2-5 minutes (IV) |
| Typical Dose | 30-100 nmol/kg/min (IV infusion, clinical) | 1-10 nmol/kg IV (research) |
| Frequency | Acute infusion protocols | Variable |
| Route | IV infusion (clinical studies); SC under investigation | IV / SC (research) |
| FDA Status | Investigational (Phase I/II) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.